Project Number ARUK-DC2017-1 Agency/Funding Organization Alzheimer's Research UK Funding Year 2017 View Full Project Details for Developing novel small molecules as effective inhibitors of the NLRP3 inflammasome Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator David Brough Principal Investigator First Name David Principal Investigator Last Name Brough Awardee Organization University of Manchester Contact PI Country United Kingdom Project Detail FY Overall Cost $191,757 Funding Organization Agency/Funding Organization Alzheimer's Research UK Funding Organization Country United Kingdom
